BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24383741)

  • 1. Pansclerotic morphea with features of eosinophilic fasciitis: distinct entities or part of a continuum?
    Odhav A; Hoeltzel MF; Canty K
    Pediatr Dermatol; 2014; 31(2):e42-7. PubMed ID: 24383741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical presentations of eosinophilic fasciitis.
    Ergun T; Seckin D; Salman A; Ocak ES; Yucelten AD; Direskeneli H; Demirkesen C; Ekinci G; Bayik M
    Indian J Dermatol Venereol Leprol; 2016; 82(1):47-52. PubMed ID: 26728810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic fasciitis/generalized morphea overlap successfully treated with azathioprine.
    Alonso-Castro L; de las Heras E; Moreno C; Fleta-Asín B; Muñoz-Zato E; Carrillo R; Jaén P
    Int J Dermatol; 2014 Nov; 53(11):1386-8. PubMed ID: 24697582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Eosinophilic fasciitis, morphea and vitiligo in a single patient].
    Lakjiri S; Meziane M; Benani A; Harmouch T; Amarti A; Mernissi FZ
    Ann Dermatol Venereol; 2014 Oct; 141(10):598-602. PubMed ID: 25288063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eosinophilic fasciitis--current knowledge].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Lipko-Godlewska S
    Przegl Lek; 2003; 60(2):116-9. PubMed ID: 12939859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fasciitis eosinophilica: personal observations and a review of the literature].
    Bobrowska-Snarska D; Ostanek L; Brzosko M
    Pol Arch Med Wewn; 2007 Apr; 117(4):64-71. PubMed ID: 17722478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphea-like plaques, induration of the extremities, and eosinophilia.
    Magro-Checa C; Orgaz-Molina J; Lafèbre SR; Rosales-Alexander JL; Arias-Santiago S; Raya E
    Cleve Clin J Med; 2015 May; 82(5):283-4. PubMed ID: 25973874
    [No Abstract]   [Full Text] [Related]  

  • 9. Deep morphea.
    Bielsa I; Ariza A
    Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized morphea developing in a patient previously affected with eosinophilic fasciitis.
    Vasani RJ; Medhekar SV
    Indian J Dermatol Venereol Leprol; 2012; 78(5):654-6. PubMed ID: 22960833
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the classification and treatment of localized scleroderma.
    Bielsa Marsol I
    Actas Dermosifiliogr; 2013 Oct; 104(8):654-66. PubMed ID: 23948159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic problems in eosinophilic fasciitis].
    Puszczewicz M; Zimmermann-Górska I; Pietrzak-Kaczmarek H; Lazowski S
    Pol Arch Med Wewn; 2006 Aug; 116(2):777-80. PubMed ID: 17424924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic Fasciitis With Concomitant Morphea Profunda Treated With Intravenous Immunoglobulin.
    Gutierrez D; Peterson EL; Kim RH; Franks AG; Lo Sicco KI
    J Clin Rheumatol; 2021 Dec; 27(8S):S500-S501. PubMed ID: 31693648
    [No Abstract]   [Full Text] [Related]  

  • 14. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic Fasciitis - Clinical Features and Therapeutic Management.
    Bilewicz-Stebel M; Bergler-Czop B; Stebel R; Weryńska-Kalemba M; Matuszewska A
    Acta Dermatovenerol Croat; 2020 Dec; 28(3):190-192. PubMed ID: 33422175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement.
    Janzen L; Jeffery JR; Gough J; Chalmers IM
    J Rheumatol; 1995 Oct; 22(10):1967-70. PubMed ID: 8992001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fasciitis-morphea complex in children.
    Miller JJ
    Am J Dis Child; 1992 Jun; 146(6):733-6. PubMed ID: 1595630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciitis eosinophilica.
    Bowszyc J; Stepień B; Janicka D
    Dermatologica; 1983; 167(6):331-4. PubMed ID: 6662258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophilic fasciitis; the importance of early detection for optimal outcomes].
    Hokken JW; van den Wall Bake AW; de Nijs RN; Westgeest AA; Kroot EJ; van Lijnschoten G
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):657-62. PubMed ID: 18438058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: A comparative study of 27 cases.
    Onajin O; Wieland CN; Peters MS; Lohse CM; Lehman JS
    J Am Acad Dermatol; 2018 Jan; 78(1):121-128. PubMed ID: 28865864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.